FUKUMORI, N.INTERNATIONAL ATOMIC ENERGY AGENCY2018-10-172018-10-172018FUKUMORI, N. <b>Quality control in the production of radiopharmaceuticals</b>. In: INTERNATIONAL ATOMIC ENERGY AGENCY (ed.); BALLINGER, J. (colab.); BRUCHERTSEIFER, F. (colab.); DOLLÉ, F. (colab.); FUKUMORI, N. (colab.); JALILIAN, A. (colab.); KRASIKOVA, R. (colab.); KVATERNIK, H. (colab.); LYASHCHENKO, S. (colab.); OCAK, M. (colab.); OSSO, J. (colab.); PANDEY, U. (colab.); SEIMBILLE, Y. (colab.); TODDE, S. (colab.). Vienna: International Atomic Energy Agency, 2018. 150p. pt. (IAEA TECDOC series, 1856). Disponível em: http://repositorio.ipen.br/handle/123456789/29239.http://repositorio.ipen.br/handle/123456789/29239Radiopharmaceuticals are central to nuclear medicine applications for the diagnosis and therapy of human diseases, especially cancers and cardiovascular diseases. In the past few decades, advances in the production and quality control of emerging radiopharmaceuticals have led to the production of new radiopharmaceuticals and the availability of new production routes and methods for existing agents. Various new diagnostic agents in the field (such as 68Ga radiopharmaceuticals and generators) as well as therapeutic agents (such as alpha emitters) have already been added to the clinician toolkit. However, the lack of generic and peer-reviewed quality control guidelines and recommendations for their application in human patients is a major concern. To address this need, and in response to requests from Member States and professional societies, the IAEA developed this publication on quality control in the production of radiopharmaceuticals. It is expected to be of use for all professionals involved in the production and quality control of radiopharmaceuticals worldwide. This publication is an outcome of the work of an international team of experts in the field between 2016 and 2018. The IAEA wishes to thank the experts for their contributions. Special thanks are due to J. Ballinger (United Kingdom) for compiling the material, and J.S. Vera Araujo (Bolivarian Republic of Venezuela) for her editorial support. The IAEA officer responsible for this publication was A.R. Jalilian of the Division of Physical and Chemical Sciences.150openAccessradiopharmaceuticalsquality controlradioisotopespharmacologydrugsproductionradioactive materialsLivroaguardando